Digital Schbang of a Pharma Breakthrough
Digital Schbang of a Pharma Breakthrough
Digital Schbang of a Pharma Breakthrough
Info
Info
Shaping the digital GTM strategy for a category-defining healthcare product
Shaping the digital GTM strategy for a category-defining healthcare product
Delivery
Delivery
Delivery
UI Design for Campaign and GTM
UI Design for Campaign and GTM
UI Design for Campaign and GTM
Pharma
Pharma
Pharma



Overview
Overview
Overview
Under strict NDA, we partnered with a leading global pharmaceutical brand to support the digital go-to-market strategy. This class of drug is considered a major breakthrough in its category, addressing one of the most pressing health concerns of our time.
Our task was to translate complex scientific insights into compelling, medically accurate digital content—crafted for healthcare professionals (HCPs), reviewed across multiple compliance layers, and built for both education and engagement.
Under strict NDA, we partnered with a leading global pharmaceutical brand to support the digital go-to-market strategy. This class of drug is considered a major breakthrough in its category, addressing one of the most pressing health concerns of our time.
Our task was to translate complex scientific insights into compelling, medically accurate digital content—crafted for healthcare professionals (HCPs), reviewed across multiple compliance layers, and built for both education and engagement.
Under strict NDA, we partnered with a leading global pharmaceutical brand to support the digital go-to-market strategy. This class of drug is considered a major breakthrough in its category, addressing one of the most pressing health concerns of our time.
Our task was to translate complex scientific insights into compelling, medically accurate digital content—crafted for healthcare professionals (HCPs), reviewed across multiple compliance layers, and built for both education and engagement.
Under strict NDA, we partnered with a leading global pharmaceutical brand to support the digital go-to-market strategy. This class of drug is considered a major breakthrough in its category, addressing one of the most pressing health concerns of our time.
Our task was to translate complex scientific insights into compelling, medically accurate digital content—crafted for healthcare professionals (HCPs), reviewed across multiple compliance layers, and built for both education and engagement.
Challenge
Challenge
Working at the intersection of medicine, marketing, and regulation, the project demanded precision and patience.
Key challenges included:
Highly technical subject matter: Understanding the mechanism of action, therapeutic use cases, and market positioning of the molecule required deep immersion and scientific literacy.
Multi-stakeholder approval loops: Every asset had to be cleared by marketing, medical, legal, finance, and product leadership—each with unique and critical requirements.
Information overload for HCPs: The drug’s potential was immense, but only if communicated clearly and succinctly to clinicians juggling limited time and attention.
Zero tolerance for inaccuracy: Every word, graphic, and visual aid needed to align with regulatory standards and approved language—no room for interpretation.
Working at the intersection of medicine, marketing, and regulation, the project demanded precision and patience.
Key challenges included:
Highly technical subject matter: Understanding the mechanism of action, therapeutic use cases, and market positioning of the molecule required deep immersion and scientific literacy.
Multi-stakeholder approval loops: Every asset had to be cleared by marketing, medical, legal, finance, and product leadership—each with unique and critical requirements.
Information overload for HCPs: The drug’s potential was immense, but only if communicated clearly and succinctly to clinicians juggling limited time and attention.
Zero tolerance for inaccuracy: Every word, graphic, and visual aid needed to align with regulatory standards and approved language—no room for interpretation.
Working at the intersection of medicine, marketing, and regulation, the project demanded precision and patience.
Key challenges included:
Highly technical subject matter: Understanding the mechanism of action, therapeutic use cases, and market positioning of the molecule required deep immersion and scientific literacy.
Multi-stakeholder approval loops: Every asset had to be cleared by marketing, medical, legal, finance, and product leadership—each with unique and critical requirements.
Information overload for HCPs: The drug’s potential was immense, but only if communicated clearly and succinctly to clinicians juggling limited time and attention.
Zero tolerance for inaccuracy: Every word, graphic, and visual aid needed to align with regulatory standards and approved language—no room for interpretation.



Solution
Solution
Our design and strategy teams worked hand-in-hand with internal pharma teams and agency partners to create a digital foundation that could scale confidently, compliantly, and intelligently.
What We Delivered:
Visualized Scientific Content: Converted dense clinical data into digestible visuals and medical illustrations—helping HCPs understand efficacy, patient fit, and dosage logic in seconds.
Education-Led Microsite: Developed a streamlined digital platform as the campaign’s backbone—serving as both a resource hub and launchpad for awareness.
Approval-Friendly Formats: Crafted templates and visual systems designed to pass through medical, legal, and brand review without friction.
Our design and strategy teams worked hand-in-hand with internal pharma teams and agency partners to create a digital foundation that could scale confidently, compliantly, and intelligently.
What We Delivered:
Visualized Scientific Content: Converted dense clinical data into digestible visuals and medical illustrations—helping HCPs understand efficacy, patient fit, and dosage logic in seconds.
Education-Led Microsite: Developed a streamlined digital platform as the campaign’s backbone—serving as both a resource hub and launchpad for awareness.
Approval-Friendly Formats: Crafted templates and visual systems designed to pass through medical, legal, and brand review without friction.
Our design and strategy teams worked hand-in-hand with internal pharma teams and agency partners to create a digital foundation that could scale confidently, compliantly, and intelligently.
What We Delivered:
Visualized Scientific Content: Converted dense clinical data into digestible visuals and medical illustrations—helping HCPs understand efficacy, patient fit, and dosage logic in seconds.
Education-Led Microsite: Developed a streamlined digital platform as the campaign’s backbone—serving as both a resource hub and launchpad for awareness.
Approval-Friendly Formats: Crafted templates and visual systems designed to pass through medical, legal, and brand review without friction.



Impact
Impact
Enabled HCP Engagement: Created clarity around a revolutionary therapy, empowering healthcare professionals to evaluate and prescribe with confidence.
Became a Trusted Creative Partner: Our ability to balance science and storytelling under high scrutiny established long-term credibility with both client and agency teams.
Protected Under NDA: Specific outcomes, data points, and branding details remain confidential under strict non-disclosure terms.
Enabled HCP Engagement: Created clarity around a revolutionary therapy, empowering healthcare professionals to evaluate and prescribe with confidence.
Became a Trusted Creative Partner: Our ability to balance science and storytelling under high scrutiny established long-term credibility with both client and agency teams.
Protected Under NDA: Specific outcomes, data points, and branding details remain confidential under strict non-disclosure terms.
Enabled HCP Engagement: Created clarity around a revolutionary therapy, empowering healthcare professionals to evaluate and prescribe with confidence.
Became a Trusted Creative Partner: Our ability to balance science and storytelling under high scrutiny established long-term credibility with both client and agency teams.
Protected Under NDA: Specific outcomes, data points, and branding details remain confidential under strict non-disclosure terms.



Prototype and Narrative
/
Boston Consulting Group
AI-Powered Brand Management: A Vision for BCG
Luxury Retail Digitisation
/
Italian Furniture Brand
Building a Digital-First Luxury Brand
UI Design for Campaign and GTM
/
Pharma
Digital Schbang of a Pharma Breakthrough
Digital First Investor
/
UX UI and Tech
Digital Transformation for Adventum
GTM and Product Design
/
Longetivity and Anti Senesance
Hyperbaric Futures
B2B Sales Platform
/
Microsoft Channel Ecosystem
Maximizing Global Reach for Channel Partners
Prototype and Strategy
/
ESG
Next-Gen Mobility: Designing India’s RRTS App
Tax Platform UX
/
EY India
Redesigning Compliance at Scale
GTM and Product Design
/
FinTech - Taxation
Simplifying GST Compliance and GTM
Immersive Digital Experience
/
Film Making Company
The Wedding Filmers: Designing a Legacy in Motion
Prototype and Narrative
/
Boston Consulting Group
AI-Powered Brand Management: A Vision for BCG
Luxury Retail Digitisation
/
Italian Furniture Brand
Building a Digital-First Luxury Brand
UI Design for Campaign and GTM
/
Pharma
Digital Schbang of a Pharma Breakthrough
Digital First Investor
/
UX UI and Tech
Digital Transformation for Adventum
GTM and Product Design
/
Longetivity and Anti Senesance
Hyperbaric Futures
B2B Sales Platform
/
Microsoft Channel Ecosystem
Maximizing Global Reach for Channel Partners
Prototype and Strategy
/
ESG
Next-Gen Mobility: Designing India’s RRTS App
Tax Platform UX
/
EY India
Redesigning Compliance at Scale
GTM and Product Design
/
FinTech - Taxation
Simplifying GST Compliance and GTM
Immersive Digital Experience
/
Film Making Company
The Wedding Filmers: Designing a Legacy in Motion